MACROGENICS INC — Director's Dealing 2022

Feb 25, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2022-02-22

Reporting Person: Peters Jeffrey Stuart (Senior VP and General Counsel)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-22	Employee stock option (right to buy)	$10.15	A	70000	Acquired	2032-02-22	Common Stock (70000.0)	Direct
2022-02-22	Restricted Stock Unit	$0.0	A	35000	Acquired		Common Stock (35000.0)	Direct

Footnotes

F1: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

F2: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

F3: The RSUs will vest as to 25% of the total shares one year after the date of grant and 75% two years after the date of grant.